# Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

> **NCT06856616** · — · ACTIVE_NOT_RECRUITING · sponsor: **The Third Affiliated Hospital of Harbin Medical University** · enrollment: 6000 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06856616
- **Lead sponsor:** The Third Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2025-11-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06856616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06856616, "Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06856616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*